.webp?width=217&height=60&name=Screenpoint-Med%20(1).webp "Screen Point Medical")
%20(1).png)
MASAI RCT: 12% reduction in interval cancer rate using Transpara
.png)
Transpara® Breast AI Selected for $16M PRISM Randomized Controlled Trial in USA
.png)
ScreenPoint Medical Enables Transpara® Breast AI within Precision Imaging Network, part of Microsoft for Healthcare
.png)
AI increases breast cancer detection – with Dr. Cathy Keller
Dr. Cathy Keller discusses how breast AI is used to improve breast screening accuracy and offers key recommendations for awareness and action.
.png)
AI can act as your second reader for breast cancer screening programmes
As leading breast cancer screening programmes look to adapt and advance, Breast AI may serve as a lifeline to better workflow and improved health outcomes.
.png)
As imaging volume increases, breast radiology workflow must adapt
Radiology faces an inflection point. Can systemic solutions, including AI, prioritize both patient outcomes and radiologist well-being?
.png)
Breast imaging is awash in data – Artificial Intelligence can help
Breast imaging has unique stressors compared to other areas of radiology that can contribute to radiologist fatigue and error: what can be done?
.png)
Podcast: ScreenPoint Co-Founder Talks Future of Breast Cancer Screening
Nico Karssemeijer, Chief Science Officer and Co-Founder of ScreenPoint Medical, joins Impact AI podcast to discuss how his team is revolutionizing breast cancer screening through cutting-edge AI.